Skip to main content
Premium Trial:

Request an Annual Quote

Bayer and Paradigm Sign Crop Protection Contract

Premium

RALEIGH, NC--German life sciences company Bayer has signed a contract with Paradigm Genetics here under which they will collaborate in a search for screening targets leading to the development of new herbicides. For contributing its expertise in bioinformatics, gene function identification, and assay development, Paradigm will receive up to $40 million, including milestone payments. Genes identified as being responsible for new targets will be subjected to high-throughput screening.

Jochen Wulff, general manager of Bayer's Crop Protection Business Group, said Paradigm's track record in discovering biochemical characteristics in plants made it a "particularly suitable partner" in gene function research. He added, "The contract marks a continuation of Bayer's strategy of collaborating with outside organizations and will enable us to use available gene technology know-how to develop new crop protection products."

Filed under

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.